BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 8310664)

  • 1. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(12):816-21. PubMed ID: 2698488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Present possibilities of treatment of primary chronic glomerulonephritis].
    Knotková V; Nĕmecek K
    Vnitr Lek; 1994 Jun; 40(6):345-8. PubMed ID: 8073642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Sheveleva LA
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS; Makurov AI
    Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
    [No Abstract]   [Full Text] [Related]  

  • 9. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ
    Semin Nephrol; 1991 Mar; 11(2):138-47. PubMed ID: 2034923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotic syndrome in the elderly. A retrospective study in steroid-treated patients.
    Palmieri PF; Bonomini M; Di Mizio G; Manfrini V; Summa R; Stuard S; Albertazzi A
    Contrib Nephrol; 1993; 105():58-64. PubMed ID: 8252872
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
    Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
    Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function.
    Jindal K; West M; Bear R; Goldstein M
    Am J Kidney Dis; 1992 Jan; 19(1):61-7. PubMed ID: 1739084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
    Kosmadakis G; Filiopoulos V; Smirloglou D; Skarlas P; Georgoulias C; Michail S
    Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
    Fujimoto S; Yamamoto Y; Wakisaka O; Hisanaga S; Miyata J; Tanaka K
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
    [No Abstract]   [Full Text] [Related]  

  • 20. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N; Robeva R; Dimitrova V
    Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.